Literature DB >> 24784142

Spectrum of mast cell activation disorders.

Anastasia I Petra1, Smaro Panagiotidou, Julia M Stewart, Pio Conti, Theoharis C Theoharides.   

Abstract

Mast cell (MC) activation disorders present with multiple symptoms including flushing, pruritus, hypotension, gastrointestinal complaints, irritability, headaches, concentration/memory loss and neuropsychiatric issues. These disorders are classified as: cutaneous and systemic mastocytosis with a c-kit mutation and clonal MC activation disorder, allergies, urticarias and inflammatory disorders and mast cell activation syndrome (MCAS), idiopathic urticaria and angioedema. MCs are activated by IgE, but also by cytokines, environmental, food, infectious, drug and stress triggers, leading to secretion of multiple mediators. The symptom profile and comorbidities associated with these disorders, such as chronic fatigue syndrome and fibromyalgia, are confusing. We propose the use of the term 'spectrum' and highlight the main symptoms, useful diagnostic tests and treatment approaches.

Entities:  

Keywords:  IgE; antihistamines; brain; c-kit mutation; inflammation; mast cell; mastocytosis; mediators; tryptase

Mesh:

Substances:

Year:  2014        PMID: 24784142     DOI: 10.1586/1744666X.2014.906302

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  21 in total

Review 1.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

Review 2.  Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

3.  The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.

Authors:  Zuyi Weng; Arti B Patel; Smaro Panagiotidou; Theoharis C Theoharides
Journal:  J Allergy Clin Immunol       Date:  2014-12-10       Impact factor: 10.793

Review 4.  Mast Cell Activation Syndrome.

Authors:  Marianne Frieri
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

5.  Understanding unspecific complaints through genetics.

Authors:  Eli Sprecher
Journal:  Nat Genet       Date:  2016-11-29       Impact factor: 38.330

Review 6.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

Review 7.  The Return of the Mast Cell: New Roles in Neuroimmune Itch Biology.

Authors:  Fang Wang; Ting-Lin B Yang; Brian S Kim
Journal:  J Invest Dermatol       Date:  2020-04-02       Impact factor: 8.551

Review 8.  Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Chiara M Conti; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Theoharis C Theoharides
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

9.  Persistent Catechol-O-methyltransferase-dependent Pain Is Initiated by Peripheral β-Adrenergic Receptors.

Authors:  Brittney P Ciszek; Sandra C O'Buckley; Andrea G Nackley
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

10.  Sleep Related Scratching: A Distinct Parasomnia?

Authors:  Gaurav Nigam; Muhammad Riaz; Shelley D Hershner; Cathy A Goldstein; Ronald D Chervin
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.